Influence of Levothyroxine With Recombinant Human Thyroid-Stimulating Hormone on Urinary Iodine Excretion Before Radioactive Iodine Administration.

Fujimoto, Kanta; Hataya, Yuji; Okubo, Marie; Matsuoka, Naoki

Fujimoto, Kanta; Hataya, Yuji; Okubo, Marie; Matsuoka, Naoki.

Afiliación

Fujimoto K; Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe, Japan. Electronic address: kantachi@kcho.jp.
Hataya Y; Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe, Japan.
Okubo M; Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe, Japan.
Matsuoka N; Department of Diabetes and Endocrinology, Kobe City Medical Center General Hospital, Kobe, Japan.

Endocr Pract ; 27(10): 1022-1027, 2021 Oct.

Article en En | MEDLINE | ID: mdl-33831554

Asunto(s)

Yodo; Neoplasias de la Tiroides; Tirotropina Alfa; Humanos; Radioisótopos de Yodo; Proteínas Recombinantes; Neoplasias de la Tiroides/radioterapia; Tirotropina; Tiroxina

Palabras clave

low iodine diet; radioactive iodine therapy; recombinant human thyroid-stimulating hormone; thyroid cancer; urinary iodine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Tirotropina Alfa / Yodo Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Endocr Pract Asunto de la revista: ENDOCRINOLOGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google